We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current RCEL market cap is 308.58M. The company's latest EPS is USD -1.3495 and P/E is -8.73.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 13.86M | 14.25M | 11.1M | 15.2M | 19.55M |
| Operating Income | -9.31M | -12.27M | -17.21M | -15.62M | -13.81M |
| Net Income | -8.71M | -7.07M | -18.66M | -15.39M | -16.21M |
| Year End 31 December 2023 | 2020 | 2021 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 18.19M | 31.29M | 13.96M | 37.64M | 51.57M |
| Operating Income | -42.68M | -26.31M | -15M | -27.51M | -42.66M |
| Net Income | -42.03M | -26.58M | -14.96M | -26.67M | -35.38M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 81.01M | 111.64M | 97.38M | 87.83M | 81.05M |
| Total Liabilities | 17.41M | 61.89M | 64.81M | 63.51M | 68.6M |
| Total Equity | 62.98M | 49.06M | 32.57M | 23.92M | 12.23M |
| Year End 31 December 2023 | 2020 | 2021 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 82.46M | 125.5M | 116.02M | 98.26M | 111.64M |
| Total Liabilities | 10.06M | 9.85M | 11.39M | 13.52M | 61.89M |
| Total Equity | 72.4M | 115.66M | 104.62M | 84.74M | 49.06M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -27.15M | -38.01M | -20.86M | -33.64M | -40.86M |
| Investing | 58.91M | 1.61M | 15.07M | 27.5M | 34.89M |
| Financing | 942k | 40.37M | 631k | 1.48M | 2.49M |
| Year End 31 December 2023 | 2020 | 2021 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -22.75M | -25.9M | -5.5M | -19.09M | -38.01M |
| Investing | -847k | -1.17M | -49.68M | -19.33M | 1.61M |
| Financing | 77.06M | 64.05M | 7k | 900k | 40.37M |
| Market Cap | 308.58M |
| Price to Earnings Ratio | -8.73 |
| Price to Sales Ratio | 5.99 |
| Price to Cash Ratio | 13.96 |
| Price to Book Ratio | 6.21 |
| Dividend Yield | - |
| Shares Outstanding | 26.22M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 1.43 (11.48%) |
| Company Name | Avita Medical Inc |
| Address |
3411 silverside road tatnall building wilmington, delaware 19810 |
| Website | https://www.avitamedical.com |
| Industry | surgical,med instr,apparatus (3841) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
